Showing 5431-5440 of 5643 results for "".
- Nicox Postpones Nasdaq Listing Due to Market Volatilityhttps://modernod.com/news/nicox-postpones-nasdaq-listing-due-to-market-volatility/2479717/Nicox SA announced that due to the extreme volatility of the financial markets, it has decided to postpone its dual listing on Nasdaq, concluding that it would not be in the interest of their existing shareholders at this time, according to a company news release. The purpose of a Nasdaq l
- Report: Laser Vision Correction Procedure Volume Increases for Third Straight Yearhttps://modernod.com/news/report-laser-vision-correction-procedure-volume-increases-for-third-straight-year/2479719/Laser vision correction procedure volume in the United States increased for the third year in a row, indicating a growing demand for LASIK and other laser vision correction procedures, according to data released by the Refractive Surgery Council (RSC). Year-to-date laser vision correction
- Study: Diabetes Medication May Protect Against AMDhttps://modernod.com/news/study-diabetes-medication-may-protect-against-amd/2479722/Researchers from Taiwan have shown that people with type 2 diabetes who took a common diabetes medication, metformin, had a significantly lower rate of age-related macular degeneration (AMD). The study suggests that the anti-inflammatory and anti-oxidative effects
- EyePoint Pharmaceuticals Presents Positive Yutiq 24-month Follow-up Data at AAOhttps://modernod.com/news/eyepoint-pharmaceuticals-presents-positive-yutuq-24-month-follow-up-data-at-aao/2479724/EyePoint Pharmaceuticals announced the presentation of 24-month efficacy and safety data supporting the company’s Yutiq (fluocinolone acetonide intravitreal implant) 0.18 mg 3-year micro-insert for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye. Th
- New STAIRWAY Study Data Shows Potential for Extended Durability with Faricimab in Wet AMDhttps://modernod.com/news/new-stairway-study-data-shows-potential-for-extended-durability-with-faricimab-in-wet-amd/2479728/Genentech announced positive results from the phase 2 STAIRWAY study which explored the extended durability of faricimab (RG7716) in the treatment of wet age-related macular degeneration (AMD). At 52 weeks, faricimab patients dosed either every 16 weeks or every 12 weeks demonstrated sustained vi
- Easier, Potentially More Effective Treatment for Blinding Eye Disease Shows Promise in Clinical Trialhttps://modernod.com/news/easier-potentially-more-effective-treatment-for-blinding-eye-disease-shows-promise-in-clinical-trial/2479730/A new study shows that an implantable delivery system for a widely used medication to treat a blinding eye disease has enabled some patients to go 15 months in between treatments. This represents a vast improvement over the typical regimen of nearly monthly eye injections. The researchers involve
- GenSight Biologics Enrolls First Subject in PIONEER Phase 1/2 Trial of Retinitis Pigmentosa Drug Candidatehttps://modernod.com/news/gensight-biologics-enrolls-first-subject-in-pioneer-phase-1-2-trial-of-retinitis-pigmentosa-drug-candidate/2479731/GenSight Biologics announced that the first subject was treated in the first-in-man PIONEER phase I/II clinical trial of GS030 at the Moorfields Eye Hospital in London, United Kingdom. “We are thrilled to see our second lead program, GS030, now entering the clinic. This is a fantastic achi
- CheckedUp Announces Expanding Reach in Vision Care and New Product Features at the Point of Carehttps://modernod.com/news/checkedup-announces-expanding-reach-in-vision-care-and-new-product-features-at-the-point-of-care/2479734/CheckedUp announced several new product features to optimize their health care decision technology. With more than 5,000 eye care professionals in the CheckedUp network, the technology empowers patients during their health care journey by engaging and educating them about their care, preventions,
- Topcon Introduces Topcon Harmony and Triton Swept Source OCT at the 2018 AAOhttps://modernod.com/news/topcon-introduces-topcon-harmony-and-triton-swept-source-oct-at-the-2018-aao/2479746/Topcon will debut the Topcon Harmony ophthalmic data management system at the AAO meeting in Chicago. Harmony replaces Synergy and features a completely redesigned browser-based user interface that includes new features and vendor-neutral connectivity. “The last few months of hard work and
- Alcon to Showcase Latest Innovations at American Academy of Ophthalmology 2018 Annual Meetinghttps://modernod.com/news/alcon-to-showcase-latest-innovations-at-american-academy-of-ophthalmology-2018-annual-meeting/2479748/Alcon will showcase several advancements in ophthalmology through a robust booth presence, a series of live demonstrations, and interactive symposia during the American Academy of Ophthalmology (AAO) 2018 annual meeting, taking place October 27-30 in Chicago, IL. “We are very excited to e